Skip to main content

Table 1 ANGPTL1 expression was significantly down regulated in cancer tissues of 14 cancer types

From: ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138

Cancer Type

Numbera

Normalb

Cancerb

log2FoldChangec

Adjusted P valued

BLCA

19

637.89

25.25

−4.66

<0.0001

BRCA

113

600.86

74.84

−3.01

<0.0001

CHOL

9

427.26

107.93

−1.98

<0.0001

CRC

32

797.1

38.74

−4.36

<0.0001

ESCA

11

816.82

40.15

−4.35

0.04

HNSC

43

418.62

31.68

−3.72

<0.0001

KIRC

72

529.9

63.99

−3.05

<0.0001

KIRP

72

439.06

80.07

−2.46

<0.0001

LUAD

58

300.09

44.4

−2.76

<0.0001

LUSC

51

309.17

27.88

−3.47

<0.0001

PRAD

52

287.12

81.15

−1.82

<0.0001

STAD

32

1520.86

154.21

−3.3

<0.0001

THCA

59

1423.74

382.68

−1.9

<0.0001

UCEC

7

1267.48

87.89

−3.85

<0.0001

  1. Abbreviations: BLCA bladder urothelial carcinoma, BRCA breast invasive carcinoma, CHOL cholangiocarcinoma, CRC colorectal cancer, ESCA esophageal carcinoma, HNSC head and neck squamous cell carcinoma, KIRC kidney renal clear cell carcinoma, KIRP kidney renal papillary cell carcinoma, LUAD lung adenocarcinoma, LUSC lung squamous cell carcinoma, PRAD prostate adenocarcinoma, STAD stomach adenocarcinoma, THCA thyroid carcinoma, UCEC uterine corpus endometrial carcinoma
  2. aNumber of paired normal and cancer tissues included in this study. We only considered the cancer type with six or more samples for differential expression analysis
  3. bMean expression level of normal or cancer tissue
  4. cFold change is calculated by mean expression level of Cancer/Normal
  5. d P value was performed by DEGSeq package for R/Bioconductor and adjusted P value was counducted according to false discovery rate